Literature DB >> 36118377

Preoperative Predictors of Extraprostatic Extension of Prostate Cancer (pT3a) in a Contemporary Indian Cohort.

Sohrab Arora1, Gagan Gautam2, Rakesh Khera3, Rajesh K Ahlawat4.   

Abstract

We present our experience with robotic radical prostatectomy and analyse the predictors for extracapsular extension (EPE) in a cohort of Indian patients. Four hundred fifty-three patients underwent robotic radical prostatectomy from May 2010 to October 2015. Post hoc analysis of prospectively maintained data was done. Multivariable regression analysis was used on variables which had significant association with EPE on univariable analysis. Receiver operating characteristic (ROC) curves were plotted for the independent predictors of EPE. Mean age was 64.62 ± 6.44 years. Mean BMI 26.03 ± 4.01 kg/m2. Median prostate-specific antigen (PSA) was 13.38 ng/ml (IQR 8.1-23.5). Seventy-seven (16.99%) patients had Gleason >7. Mean core positivity (percentage of cores positive) was 48,93 ± 27.29% and mean maximum percentage of tumour in a core was 33,04 ± 31.16%. Positive surgical margins were present in 141/453 (31.15%). Lymph nodes were positive in 21.2% of those who had nodes removed (77/364). Maximum cancer in a core (p < 0.001), core positivity (p = 0.002) and Gleason score ≥4 + 3 (p = 0.028) were significant predictors of EPE, independent of BMI, PSA, PNI and clinical stage. Receiver operating characteristic (ROC) analysis for core positivity showed an area under the curve (AUC) of 0.775, and a 76% core positivity predicted EPE with a sensitivity of 65% and a specificity of 87.1%, respectively. ROC curve for maximum cancer in a core showed an area under the curve of 0.898. Seventy per cent cancer in a single core predicted EPE with a sensitivity of 80.6% and a specificity of 85.9% Indian patients present with more advanced disease, higher PSA and have higher incidence of EPE. Maximum cancer in a core, ratio of positive cores and Gleason score ≥4 + 3 are predictors of EPE independent of PSA and clinical stage. © Indian Association of Surgical Oncology 2017.

Entities:  

Keywords:  Extraprostatic extension; Prostate cancer; Robotic prostatectomy

Year:  2017        PMID: 36118377      PMCID: PMC9478066          DOI: 10.1007/s13193-017-0671-0

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  21 in total

1.  Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.

Authors:  A W Partin; L A Mangold; D M Lamm; P C Walsh; J I Epstein; J D Pearson
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

2.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

Authors:  A W Partin; M W Kattan; E N Subong; P C Walsh; K J Wojno; J E Oesterling; P T Scardino; J D Pearson
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

3.  The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.

Authors:  T J Sebo; B J Bock; J C Cheville; C Lohse; P Wollan; H Zincke
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

4.  Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.

Authors:  Danil V Makarov; Bruce J Trock; Elizabeth B Humphreys; Leslie A Mangold; Patrick C Walsh; Jonathan I Epstein; Alan W Partin
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

5.  Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension.

Authors:  Yoshio Naya; Joel W Slaton; Patricia Troncoso; Koji Okihara; R Joseph Babaian
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

6.  Prostate cancer disease characteristics for foreign-born South Asian men living in the United States.

Authors:  T Patel; C C Wambi; W Berg; M D Inusa; M Menon; K Badani
Journal:  Indian J Cancer       Date:  2013 Jul-Sep       Impact factor: 1.224

7.  Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.

Authors:  Rajeev Kumar; Rishi Nayyar; Virendra Kumar; Narmada P Gupta; Ashok K Hemal; N R Jagannathan; S Dattagupta; S Thulkar
Journal:  Urology       Date:  2008-03-10       Impact factor: 2.649

8.  Predictive factors for lymph node positivity in patients undergoing extended pelvic lymphadenectomy during robot assisted radical prostatectomy.

Authors:  Vikram Batra; Gagan Gautam; Jiten Jaipuria; Manav Suryavanshi; Rakesh Khera; Rajesh Ahlawat
Journal:  Indian J Urol       Date:  2015 Jul-Sep

Review 9.  Epidemiology of prostate cancer in India.

Authors:  Shalu Jain; Sunita Saxena; Anup Kumar
Journal:  Meta Gene       Date:  2014-08-29

10.  Continence outcomes following robotic radical prostatectomy: Our experience from 150 consecutive patients.

Authors:  Narmada P Gupta; Rajiv Yadav; Emmanuel E Akpo
Journal:  Indian J Urol       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.